Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eslicarbazepine acetate for diabetic neuropathic pain
2010-019100-23Phase 3Completed
- Sponsor
- BIAL
- Start
- Jun 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of eslicarbazepine acetate in diabetic neuropathy and diabetic polyneuropathy (DPN) (3 arms), sponsored by BIAL. Primary endpoint: Change from baseline to endpoint in mean pain. Started Jun 2010; status: completed.
02
Drugs
eslicarbazepine acetate
03
Conditions
diabetic neuropathydiabetic polyneuropathy (DPN)
Beyond the preview
Go deeper on 2010-019100-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019100-23.